Short-term symptomatic treatment of acute exacerbations of rheumatoid arthritis or ankylosing spondylitis, when oral or rectal use is not applicable.
Meloxicam 15 mg in the form of an enolic salt formed in situ during production.
Short-term symptomatic treatment of acute exacerbations of rheumatoid arthritis or ankylosing spondylitis, when oral or rectal use is not applicable. Meloxicam 15mg/1.5 ml solution for injection is indicated for use in adults.
For intramuscular use: 15 mg once daily.
THE TOTAL DAILY DOSE SHOULD NOT EXCEED 15MG.
